Skip to content

Price / earnings at other companies

LivaNova logo
LivaNovaLIVN
39.8×-119×
Edwards Lifesciences logo
Edwards LifesciencesEW
42.1×+32.0×
United Therapeutics logo
United TherapeuticsUTHR
20.2×+8.8×
OSI Systems logo
OSI SystemsOSIS
28.7×+5.7×

Other financials

Income statement

See full
Revenue$173.9M+21.2%
Gross profit$101.2M+14.7%
Operating income$13.3M-51.5%
Net income$7.3M-71.5%
EPS (diluted)$0.20-71.4%

Balance sheet

See full
Cash & equivalents$461.7M+48.9%
Total debt$409.9M+505%
Total equity$494.0M+85.5%
Total assets$1.4B+71.3%

Cash flow

See full
Operating cash flow$24.5M+959%
CapEx$36.7M+35.6%
Free cash flow-$12.1M+59.4%

Valuation

See full
Market cap$2.55B+50.6%
Enterprise value$2.5B+66.0%
P/S+0.5×

Profitability

See full
Gross margin59.1%-0.4pp
Operating margin14.9%+4.1pp
Net margin27%+17.0pp
FCF margin23.8%

Returns & leverage

See full
Return on equity45.2%+22.2pp
Debt / equity0.8×+0.6×
Current ratio6.7×-2.4×

Where this comes from

Calculated from TransMedics Group, Inc.’s reported figures.

Based on the most recent quarter.

The official record: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about TransMedics Group, Inc.'s price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TransMedics Group, Inc.'s price / earnings?
TransMedics Group, Inc. (TMDX) reported price / earnings of 19.8× in Q1 2026.
How has TransMedics Group, Inc.'s price / earnings changed year-over-year?
TransMedics Group, Inc.'s price / earnings decreased by 57.1% year-over-year, from 46.3× to 19.8×.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.